Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dentsply SironaXRAY +5.68%59 3-1 Month Momentum % is -1.35% as of Aug. 04, 2026. GuruFocus rates XRAY with a GF Score™ of 59/100 and a GF Value™ of $18.98 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Dentsply Sirona ranks better than 61.27% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-04), Dentsply Sirona's 3-1 Month Momentum % is -1.35%.
The industry rank for Dentsply Sirona's 3-1 Month Momentum % or its related term are showing as below:
XRAY's 3-1 Month Momentum % is ranked better than 61.27% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: -6.115
vs XRAY: -1.35
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Dentsply Sirona 3-1 Month Momentum % Related Terms
XRAY vs LMAT, WRBY, PLSE: 3-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona (XRAY) has a 3-1 Month Momentum % of -1.35% as of Aug. 04, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Dentsply Sirona and its competitors. According to the industry distribution chart, Dentsply Sirona ranks #330 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 38.7%.
Is Dentsply Sirona's 3-1 Month Momentum % too high?
Dentsply Sirona's current 3-1 Month Momentum % is -1.35%. Based on the distribution chart, Dentsply Sirona ranks #330 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's 3-1 Month Momentum % compare to LMAT and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #330 out of 852 companies for 3-1 Month Momentum %. This puts Dentsply Sirona in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Dentsply Sirona and its competitors. Dentsply Sirona's current 3-1 Month Momentum % is -1.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.98, compared to a current price of $14.15 — trading 25.4% below its estimated fair value. The current 3-1 Month Momentum % is -1.35%. Dentsply Sirona's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current 3-1 Month Momentum % is -1.35% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $14.15 is trading 25.4% below its estimated GF Value™ of $18.98.
GuruFocus considers Dentsply Sirona to be Modestly Undervalued.
Key valuation signals for XRAY:
3-1 Month Momentum %: -1.35%
GF Value™: $18.98 vs. price of $14.15 (25.4% below fair value)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
59GF Score
Get the complete analysis for XRAY
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
